New therapeutic avenues in lung cancer based on disturbances in PI3K and RAS pathways

被引：0
|
作者：
Rosell, R. [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Oncol, Badalona, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
G1
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes
    Li-E Wang
    Hongxia Ma
    Katherine S. Hale
    Ming Yin
    Larissa A. Meyer
    Hongliang Liu
    Jie Li
    Karen H. Lu
    Bryan T. Hennessy
    Xuesong Li
    Margaret R. Spitz
    Qingyi Wei
    Gordon B. Mills
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 377 - 385
  • [22] Co-Targeting of the PI3K and RAS Pathways for the Treatment of Carcinoid Tumors
    Valentino, Joseph
    Li, Jing
    Kim, Ji Tae
    Song, Jun
    Mustain, W. C.
    Weiss, Heidi L.
    Anthony, Lowell
    Townsend, Courtney M.
    Evers, B. Mark
    GASTROENTEROLOGY, 2012, 142 (05) : S644 - S644
  • [23] Inhibiting PI3K as a therapeutic strategy against cancer
    Paz-Ares, Luis
    Blanco-Aparicio, Carmen
    Garcia-Carbonero, Rocio
    Carnero, Amancio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (09): : 572 - 579
  • [24] Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis
    Cakir, Mehtap
    Grossman, Ashley B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (09) : 1121 - 1134
  • [25] Inhibiting PI3K as a therapeutic strategy against cancer
    Luis Paz-Ares
    Carmen Blanco-Aparicio
    Rocío García-Carbonero
    Amancio Carnero
    Clinical and Translational Oncology, 2009, 11 : 572 - 579
  • [26] The PI3K Pathway as a Therapeutic Target in Breast Cancer
    Ma, Cynthia X.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (03) : 23 - 29
  • [27] Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
    Qiang, Min
    Chen, Zhe
    Liu, Hongyang
    Dong, Junxue
    Gong, Kejian
    Zhang, Xinjun
    Huo, Peng
    Zhu, Jingjun
    Shao, Yifeng
    Ma, Jinazun
    Zhang, Bowei
    Liu, Wei
    Tang, Mingbo
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [28] Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment
    Castely, Pau
    Toskay, Eneda
    Zumsteg, Zachary S.
    Carmona, F. Javier
    Elkabets, Moshe
    Bosch, Ana
    Scaltriti, Maurizio
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (03)
  • [29] The Biological Role of PI3K Pathway in Lung Cancer
    Sarris, Evangelos G.
    Saif, Muhammad W.
    Syrigos, Kostas N.
    PHARMACEUTICALS, 2012, 5 (11) : 1236 - 1264
  • [30] New roles for PI3K isoforms in cancer
    Vanhaesebroeck, Bart
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
12345